CNS Pharmaceuticals CNSP
NASDAQ CNSP
$5.25 +0.34 (+6.98%)
As of: Sep 30, 2026 · 11:39 AM EDT

CNS Pharmaceuticals, Inc. (CNSP) Debt Ratio (2018 - 2025)

Updated

CNS Pharmaceuticals' Debt Ratio was 0.04 in Q4 2025, up 1.7% from 0.04 a year earlier.

Analysis

CNS Pharmaceuticals, Inc. (CNSP) Debt Ratio (2018 - 2025) Analysis & Trends

From Q4 2018 onward, CNS Pharmaceuticals has reported Debt Ratio for 23 quarters.

  • In earlier years, Debt Ratio was 0.04 in FY2024 (-78.8%), 0.18 in FY2023 (+463.1%), 0.03 in FY2022 (-29.1%) and 0.04 in FY2021 (+59.8%).
  • The Q4 2025 figure marks the highest quarterly Debt Ratio since Q2 2024.
  • Compared with a year earlier, Debt Ratio was higher in three of the last eight quarters, with an average decline of 5.1%.
  • The best year-over-year quarter for Debt Ratio over five years was Q4 2023 (growth of 463.1%); the worst was Q1 2025 (a decline of 88.1%).
  • Per Business Quant data, CNSP's Debt Ratio in the three quarters before Q4 2025 was 0.00 (Q3 2025), 0.01 (Q2 2025) and 0.02 (Q1 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.04
Sep 30, 2025 0.00
Jun 30, 2025 0.01
Mar 31, 2025 0.02
Dec 31, 2024 0.04
Sep 30, 2024 0.00
Jun 30, 2024 0.05
Mar 31, 2024 0.13
Dec 31, 2023 0.18
Sep 30, 2023 0.02
Jun 30, 2023 0.03
Mar 31, 2023 0.04
Dec 31, 2022 0.03
Sep 30, 2022 0.00
Jun 30, 2022 0.01
Mar 31, 2022 0.02
Dec 31, 2021 0.04
Sep 30, 2021 0.00
Jun 30, 2021 0.01
Mar 31, 2021 0.02
API Access

CNS Pharmaceuticals, Inc. Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CNSP&period=max&api_key=YOUR_API_KEY